Original Source(s)
Related Content
New Immune Target in Dry Eye
Investigators say rexinoid therapy may represent a new class of dry eye treatment focused on regenerative immune signaling
June 30, 2026
-
3 min
Keratoconus Care Continues to Evolve
Susan Gromacki, OD, MS, FAAO, FSLS, Dipl AAO, and Clark Chang, OD, FAAO, FSLS, reviewed the latest developments in diagnosis, imaging, contact lenses, corneal cross-linking (CXL), and surgical management for KC.
June 17, 2026
-
4 min